Sebum: a window into dysregulation of lipid metabolism in Parkinson’s disease

30 June 2020, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A metabolomics profiling approach was conducted to identify diagnostic biomarkers of PD from sebum, a non-invasively available biofluid. In this study, we used liquid chromatography-mass spectrometry (LC-MS) to analyse 274 samples from participants (80 drug naïve PD, 138 medicated PD and 56 well matched control subjects) and detected metabolites that could predict PD phenotype. Partial least squares-discriminant analysis (PLS-DA) models based on this sebum metabolome had correct classification rates of 70.4% and 69.7% to distinguish between drug naïve PD and medicated PD from control, respectively. Variable importance in projection (VIP) scores indicate compounds with significance belonged to sphingolipid, triacylglycerol and fatty acid/ester lipid classes. Pathway enrichment analysis showed alterations in lipid metabolism and mitochondrial dysfunction viz. the carnitine shuttle, sphingolipid metabolism and arachidonic acid metabolism. This study unveiled novel diagnostic sebum-based biomarkers for PD, and provides insight towards our current understanding of the pathogenesis of PD.

Keywords

Parkinsons Diease
Metabolomics
Sebum
LC-MS
diagnosis noninvasively

Supplementary materials

Title
Description
Actions
Title
E.Sinclair LMS Sebum Parkinsons disease Supplementary Information
Description
Actions
Title
Clean ReSubmission E.Sinclair LCMS
Description
Actions
Title
Clean ReSubmission LCMS Supplementary Information
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.
Comment number 1, kim Lang: Nov 14, 2024, 18:42

I used TTFD, Amantadine, Anticholinergic, Dopamine agonist and Levodopa in the past though they helped a little for short period of time with enormous side effects and my Parkinson Disease symptoms frequently kept coming back but this time very bad and worsen due to the pharmaceutical treatments I was using. So! I had to decide to stop them all, and that was before I found out about MHC PD-50hc health protocol which I discovered on the internet, I was tagged on the MCH PD-50hc protocol immediately I ordered it from MHC which I was guided through. The MHC PD-50hc protocol drastically restore and revive my PD ill health to a good normal health though the damages PD has caused me, some still remains but I was guaranteed that they will gradually align with time which I started observing in the past 6 months now, I was told that my condition has been lifted that my PD won’t progress anymore and that i believe because many of my symptoms has stopped after using this MCH PD-50hc protocol that I got from www.madidaherbalcenter.weebly.com, the good news is I am back on my feet and can walk and work by myself now. You can go ahead and explore their site and seek their help if you need any; Email: [email protected] website:  www.madidaherbalcenter.weebly.com Facebook page: https://facebook.com/madidaherbalcenter.  Thank you all.